8.725

0.32% 0.015

Bicycle Therapeutics Plc Adr (BCYC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$8.71

Offen:

$8.7

24-Stunden-Volumen:

81,781

Relative Volume:

0.27

Marktkapitalisierung:

$416.72M

Einnahmen:

$36.90M

Nettoeinkommen (Verlust:

$-166.28M

KGV:

-2.652

EPS:

-3.29

Netto-Cashflow:

$-203.53M

1W Leistung:

+8.68%

1M Leistung:

+19.53%

6M Leistung:

-32.68%

1J Leistung:

-62.93%

1-Tages-Spanne:

$8.59

$8.8868

1-Wochen-Bereich:

$7.91

$9.0702

52-Wochen-Spanne:

$6.10

$28.67

Bicycle Therapeutics Plc Adr Stock (BCYC) Company Profile

Firmenname

Bicycle Therapeutics Plc Adr

Sektor

Healthcare (1167)

Branche

Biotechnology (653)

Telefon

011441223261503

Adresse

BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE

Mitarbeiter

305

Twitter

@Bicycle_tx

Nächster Verdiensttermin

2024-10-31

Neueste SEC-Einreichungen

BCYC's Discussions on Twitter

Vergleichen Sie BCYC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BCYC Bicycle Therapeutics Plc Adr	8.725	579.66M	36.90M	-166.28M	-203.53M	-3.29
VRTX Vertex Pharmaceuticals Inc	475.19	120.73B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	571.92	60.56B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	331.46	42.41B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	589.03	34.96B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	296.04	31.99B	3.81B	-644.79M	-669.77M	-6.24

Bicycle Therapeutics Plc Adr Stock (BCYC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-08	Eingeleitet	Stephens	Equal-Weight
2024-09-06	Eingeleitet	RBC Capital Mkts	Outperform
2024-08-07	Herabstufung	B. Riley Securities	Buy → Neutral
2023-09-11	Hochstufung	B. Riley Securities	Neutral → Buy
2022-08-31	Eingeleitet	Cowen	Outperform
2022-07-28	Eingeleitet	Barclays	Overweight
2022-07-06	Fortgesetzt	Canaccord Genuity	Buy
2022-04-13	Herabstufung	B. Riley Securities	Buy → Neutral
2022-04-07	Fortgesetzt	Cantor Fitzgerald	Overweight
2022-02-14	Eingeleitet	Morgan Stanley	Equal-Weight
2021-12-17	Eingeleitet	SVB Leerink	Outperform
2021-12-09	Eingeleitet	Needham	Buy
2021-09-30	Eingeleitet	B. Riley Securities	Buy
2021-04-20	Eingeleitet	JMP Securities	Mkt Outperform
2020-10-12	Eingeleitet	Cantor Fitzgerald	Overweight
2020-06-12	Eingeleitet	Oppenheimer	Outperform
2020-04-17	Eingeleitet	H.C. Wainwright	Buy
2019-11-14	Eingeleitet	ROTH Capital	Buy
2019-09-11	Hochstufung	Goldman	Neutral → Buy
2019-06-17	Eingeleitet	Canaccord Genuity	Buy
2019-06-17	Eingeleitet	Goldman	Neutral
2019-06-17	Eingeleitet	Jefferies	Buy
2019-06-17	Eingeleitet	Piper Jaffray	Overweight

Alle ansehen

Bicycle Therapeutics Plc Adr Aktie (BCYC) Neueste Nachrichten

Jul 17, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Teacher Retirement System of Texas - Defense World

Jul 17, 2025

Principal Financial Group Inc. Boosts Stock Position in Schneider National, Inc. (NYSE:SNDR) - Defense World

Jul 17, 2025

Principal Financial Group Inc. Purchases 1,695 Shares of Monarch Casino & Resort, Inc. (NASDAQ:MCRI) - Defense World

Jul 17, 2025

Teacher Retirement System of Texas Has $465,000 Stake in Beam Therapeutics Inc. (NASDAQ:BEAM) - Defense World

Jul 17, 2025

Teacher Retirement System of Texas Sells 1,266 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

Jul 17, 2025

Teacher Retirement System of Texas Has $534,000 Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jul 17, 2025

William Blair Brokers Decrease Earnings Estimates for TLX - Defense World

Jul 17, 2025

Principal Financial Group Inc. Boosts Stake in Capri Holdings Limited (NYSE:CPRI) - Defense World

Jul 17, 2025

First Northwest Bancorp (FNWB) Expected to Announce Quarterly Earnings on Thursday - Defense World

Jul 17, 2025

Jul 04, 2025

The Bank of Nova Scotia (TSE:BNS) Receives Average Rating of “Hold” from Analysts - Defense World

Jul 04, 2025

Jun 22, 2025

Bicycle Therapeutics (NASDAQ:BCYC) Shares Gap Up – Should You Buy? - Defense World

Jun 22, 2025

May 26, 2025

Bicycle Therapeutics’ SWOT analysis: stock faces pivotal phase amid clinical progress - Investing.com India

May 26, 2025

May 07, 2025

Market Update: Bicycle Therapeutics Plc ADR (BCYC) Sees Negative Movement, Closing at 7.40 - DWinneX

May 07, 2025

May 01, 2025

Bicycle Therapeutics earnings missed by $0.03, revenue topped estimates - Investing.com South Africa

May 01, 2025

Apr 24, 2025